yohimbine has been researched along with Myeloproliferative Disorders in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnett, DB; Pearson, D; Swart, SS; Wood, JK | 1 |
| Barnett, DB; Maguire, M; Swart, SS; Wood, JK | 1 |
| Barnett, DB; Swart, SS; Wood, JK | 1 |
3 other study(ies) available for yohimbine and Myeloproliferative Disorders
| Article | Year |
|---|---|
Functional significance of the platelet alpha2-adrenoceptor: studies in patients with myeloproliferative disorders.
Topics: Adenine Nucleotides; Adolescent; Adult; Aged; Blood Platelets; Epinephrine; Humans; Middle Aged; Myeloproliferative Disorders; Platelet Aggregation; Receptors, Adrenergic, alpha; Thromboxane B2; Yohimbine | 1984 |
Alpha 2-adrenoceptor coupling to adenylate cyclase in adrenaline insensitive human platelets.
Topics: Adenylyl Cyclases; Alprostadil; Blood Platelets; Chromatography, Gel; Epinephrine; Guanylyl Imidodiphosphate; Humans; In Vitro Techniques; Myeloproliferative Disorders; Platelet Aggregation; Receptors, Adrenergic, alpha; Yohimbine | 1985 |
Differential labeling of platelet alpha 2 adrenoceptors by 3H dihydroergocryptine and 3H yohimbine in patients with myeloproliferative disorders.
Topics: Blood Platelets; Dihydroergotoxine; Epinephrine; Humans; Myeloproliferative Disorders; Platelet Aggregation; Receptors, Adrenergic, beta; Reference Values; Tritium; Yohimbine | 1985 |